Coronavirus Updates: Johnson & Johnson Launches Phase 3 Vaccine Trial On 60,000 Participants

Gothamist

Published

Times Square

Johnson & Johnson has said that it is seeking to deliver a vaccine for emergency federal approval by early next year. [ more › ]

Full Article